FREE WEBINAR
Maximizing Financial Outcomes: Data-Driven Strategies for RCM Workflow Prioritization
In this webinar, we will explore how understanding historical data on payments, denials, payor activities, and denial types can strategically position RCM teams for improved collections and resource utilization. Join us to discover how data-driven decision-making can revolutionize revenue cycle management processes and drive financial success.
Previously aired April 17, 2024 at 1:00pm EST
60-Minute Webinar Sponsored By
The revenue cycle management (RCM) industry is facing a wealth of data but often lacks the technology to fully harness its potential. While current RCM software queues denial types, there is often a disconnect between teams' efforts and financially beneficial claims. Individual decision-making on claims can result in chasing denials that yield little financial value and can incur higher internal staff costs compared to collections.
This presentation advocates for leveraging technology to prioritize claims with the greatest financial potential, while also managing timely filing restrictions. By implementing data-drive strategies, RCM teams can streamline workflows, optimize resource allocation, and enhance financial control.
Join us on and learn how to:
- Understand the importance of leveraging historical data in revenue cycle management to strategically position teams for improved collections and resource utilization
- Learn how to identify trends in payment data, denial types, and payor activities to prioritize claims with the highest financial potential
- Explore strategies for optimizing RCM workflows by integrating data-driven decision-making processes into daily operations
- Discover how leveraging technology and data-driven strategies can enhance financial control, streamline workflows, and maximize revenue outcomes in RCM
Expert Panel
Seth Maheu
CEO
Birdrock Laboratories
Seth Maheu is CEO of Birdrock Laboratories, a clinical reference laboratory offering a diverse range of diagnostic services, including toxicology, PCR, and blood chemistry testing. With over a decade of multifaceted experience in the diagnostics industry, Seth has inhabited various roles, from his humble beginnings as an intern in accessioning to laboratory sales and ultimately into the realm of laboratory management. In 2017, his journey led him to co-acquire Birdrock Laboratories, subsequently orchestrating a remarkable 5300% increase in total revenue. Seth attributes this meteoric rise to the collective efforts of an exceptional team, a relentless dedication to customer service, and a commitment to continuous improvement, underscored by the strategic implementation of cutting-edge technology. Seth authored Birdrock’s recent expansion into clinical trial and validation services and serves as the Chief Executive Officer at Sequence Sciences, where he continues to leverage his expertise to drive innovation and propel organizational growth.